Advanced search
Publication Cover
Cancer Investigation Volume 10, 1992 - Issue 3
Submit an article Journal homepage
12
Views
39
CrossRef citations to date
0
Altmetric
Original Article

Immunotherapy of Minimal Residual Disease by Immunocompetent Lymphocytes and Their Activation by Cytokines

Hematology

Shimon Slavin Department of Bone Marrow Transplantation and Cancer Immunoblology Research Program, Hadassah University Hospital, 91120, Jerusalem, Israel
,
Aliza Ackerstein Department of Bone Marrow Transplantation and Cancer Immunoblology Research Program, Hadassah University Hospital, 91120, Jerusalem, Israel
,
Lola Weiss Department of Bone Marrow Transplantation and Cancer Immunoblology Research Program, Hadassah University Hospital, 91120, Jerusalem, Israel
,
Arnon Nagler Department of Bone Marrow Transplantation and Cancer Immunoblology Research Program, Hadassah University Hospital, 91120, Jerusalem, Israel
,
Reuven Or Department of Bone Marrow Transplantation and Cancer Immunoblology Research Program, Hadassah University Hospital, 91120, Jerusalem, Israel
&
Elizabeth Naparstek Department of Bone Marrow Transplantation and Cancer Immunoblology Research Program, Hadassah University Hospital, 91120, Jerusalem, Israel
Pages 221-227 | Published online: 11 Jun 2009

Citations (39)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Gabor Varadi, Reuven Or, Joseph Kapelushnik, Elisabeth Naparstek, Arnon Nagler, Cham Brautbar, Avraham Amar, Mark Kirschbaum, Simcha Samuel, Shimon Slavin & Tali Siegal. (1999) Graft-Versus-Lymphoma Effect after Allogeneic Peripheral Blood Stem Cell Transplantation for Primary Central Nervous System Lymphoma. Leukemia & Lymphoma 34:1-2, pages 185-190.
Read now
David L. Porter & Joseph H. Antin. (1995) Adoptive Immunotherapy for Relapsed Leukemia Following Allogeneic Bone Marrow Transplantation. Leukemia & Lymphoma 17:3-4, pages 191-197.
Read now

Articles from other publishers (37)

. 2014. Mollison's Blood Transfusion in Clinical Medicine. Mollison's Blood Transfusion in Clinical Medicine 611 659 .
Anita J. Kumar, Elizabeth O. Hexner, Noelle V. Frey, Selina M. Luger, Alison W. Loren, Ran Reshef, Jean Boyer, Jacqueline Smith, Edward A. Stadtmauer, Bruce L. Levine, Carl H. June, David L. Porter & Steven C. Goldstein. (2013) Pilot Study of Prophylactic Ex Vivo Costimulated Donor Leukocyte Infusion After Reduced-Intensity Conditioned Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 19:7, pages 1094-1101.
Crossref
Alison Rager & David L. Porter. (2011) Cellular therapy following allogeneic stem-cell transplantation. Therapeutic Advances in Hematology 2:6, pages 409-428.
Crossref
Shimon Slavin, Aliza Ackerstein, Reuven Or, Michael Y. Shapira, Benjamin Gesundheit, Nadir Askenasy & Shoshana Morecki. (2010) Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study. Cancer Immunology, Immunotherapy 59:10, pages 1511-1519.
Crossref
Edwin P. Alyea, Shuli Li, Haesook T. Kim, Corey Cutler, Vincent Ho, Robert J. Soiffer & Joseph H. Antin. (2008) Sirolimus, Tacrolimus, and Low-Dose Methotrexate as Graft-versus-Host Disease Prophylaxis in Related and Unrelated Donor Reduced-Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 14:8, pages 920-926.
Crossref
Roi Avraham, Shelly Inbar, Ella Rosenne & Shamgar Ben-Eliyahu. (2006) Autologous control of a highly malignant syngeneic CRNK-16 leukemia in the rat: a role for NK cells. Cancer Immunology, Immunotherapy 55:11, pages 1348-1357.
Crossref
. 2005. Mollison's Blood Transfusion in Clinical Medicine. Mollison's Blood Transfusion in Clinical Medicine 611 665 .
Iris Yung, Lola Weiss, Ali Abdul-Hai, Judith Kasir, Shoshana Reich & Shimon Slavin. (2005) Induction of Early Post-Transplant Graft-versus-Leukemia Effects Using Intentionally Mismatched Donor Lymphocytes and Elimination of Alloantigen-Primed Donor Lymphocytes for Prevention of Graft-versus-Host Disease. Cancer Research 65:21, pages 9735-9740.
Crossref
Shimon Slavin. (2005) Allogeneic Cell-Mediated Immunotherapy at the Stage of Minimal Residual Disease following High-Dose Chemotherapy Supported by Autologous Stem Cell Transplantation. Acta Haematologica 114:4, pages 214-220.
Crossref
David Porter, John Levine & Hans-Jochem Kolb. 2004. Graft vs. Host Disease, Third Edition. Graft vs. Host Disease, Third Edition 525 553 .
L Weiss, S Reich, O Mandelboim & S Slavin. (2004) Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy. Bone Marrow Transplantation 33:11, pages 1137-1141.
Crossref
Sally Arai & Hans-G. Klingemann. (2018) Role of Immunotherapy in Stem Cell Transplantation. International Journal of Hematology 77:1, pages 22-28.
Crossref
B Fehse, O S Kustikova, Z Li, A Wahlers, W Bohn, W R Beyer, D Chalmers, P Tiberghien, K Kühlcke, A R Zander & C Baum. (2002) A novel ‘sort-suicide’ fusion gene vector for T cell manipulation. Gene Therapy 9:23, pages 1633-1638.
Crossref
David L. Porter. (2001) The Graft-versus-Tumor Potential of Allogeneic Cell Therapy: An Update on Donor Leukocyte Infusions and Nonmyeloablative Allogeneic Stem Cell Transplantation. Journal of Hematotherapy & Stem Cell Research 10:4, pages 465-480.
Crossref
C. Schmid, A. Muth, M. Humann, G. Ledderose, C. Salat, R. Munker, M. Schleuning, E. Holler & H.-J. Kolb. 2001. Acute Leukemias VIII. Acute Leukemias VIII 665 673 .
Arnon Nagler, Aliza Ackerstein, Reuven Or, Elizabeth Naparstek & Shimon Slavin. (2000) Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation. Experimental Hematology 28:11, pages 1225-1231.
Crossref
Shoshana MoreckiShimon Slavin. (2000) Toward Amplification of a Graft-Versus-Leukemia Effect While Minimizing Graft-Versus-Host Disease. Journal of Hematotherapy & Stem Cell Research 9:3, pages 355-366.
Crossref
John BarrettShoshana Morecki, Gabor Varadi, Elizabeth Naparstek, Rami Ben-Yosef, Shimon Slavin, Arnon Nagler & Reuven Or. 2000. Allogeneic Immunotherapy for Malignant Diseases. Allogeneic Immunotherapy for Malignant Diseases.
M. Hokland, H. Jørgensen, Mette Skov Holm, Bengt Simonsson, Bo Nilsson, Mats Bengtsson & P. Hokland. (2009) Natural effector cells in patients with acute myeloid leukemia treated with the immunomodulator Linomide after autologous bone marrow transplantation. European Journal of Haematology 63:4, pages 251-258.
Crossref
David L. PorterJean M. ConnorsVivianna M.D. Van DeerlinKathleen M. DuffyCarol McGarigleSusan L. SaidmanDebra G.B. LeonardJoseph H. Antin. (1999) Graft-Versus-Tumor Induction With Donor Leukocyte Infusions as Primary Therapy for Patients With Malignancies. Journal of Clinical Oncology 17:4, pages 1234-1234.
Crossref
Urania Vourka-Karussis, Aliza Ackerstein, Thea Pugatsch & Shimon Slavin. (1999) Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease. Experimental Hematology 27:3, pages 461-469.
Crossref
David L. Porter & Joseph H. Antin. (1998) INFUSION OF DONOR PERIPHERAL BLOOD MONONUCLEAR CELLS TO TREAT RELAPSE AFTER TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA. Hematology/Oncology Clinics of North America 12:1, pages 123-150.
Crossref
S. Slavin & A. Nagler. (1998) Immunotherapy in conjunction with autologous and allogeneic blood or marrow transplantation in lymphoma. Annals of Oncology 9, pages S31-S39.
Crossref
H.M. LokhorstA. SchattenbergJ.J. CornelissenL.L.M. ThomasL.F. Verdonck. (1997) Donor Leukocyte Infusions Are Effective in Relapsed Multiple Myeloma After Allogeneic Bone Marrow Transplantation. Blood 90:10, pages 4206-4211.
Crossref
A. NaglerA. AckersteinR. OrE. NaparstekS. Slavin. (1997) Immunotherapy With Recombinant Human Interleukin-2 and Recombinant Interferon-α in Lymphoma Patients Postautologous Marrow or Stem Cell Transplantation. Blood 89:11, pages 3951-3959.
Crossref
SHOSHANA MORECKI, YAEL GELFAND, SARIT LEVI, ARNON NAGLER, REBA CONDIOTTI, CORINNE NABET, ALIZA ACKERSTEIN & SHIMON SLAVIN. (1997) Activated Long-Term Peripheral Blood Cultures as Preparation for Adoptive Alloreactive Cell Therapy in Cancer Patients. Journal of Hematotherapy 6:2, pages 115-124.
Crossref
S. Morecki, Y. Moshel, Y. Gelfend, T. Pugatsch & S. Slavin. (1997) Induction of graft vs. tumor effect in a murine model of mammary adenocarcinoma. International Journal of Cancer 71:1, pages 59-63.
Crossref
Marian RochaVictor UmanskyKyeong-Hee LeeHans-Jörg HackerAxel BennerVolker Schirrmacher. (1997) Differences Between Graft-Versus-Leukemia and Graft-Versus-Host Reactivity. I. Interaction of Donor Immune T Cells With Tumor and/or Host Cells. Blood 89:6, pages 2189-2202.
Crossref
H. J. Kolb. 1997. Symposium in Immunology VI. Symposium in Immunology VI 57 76 .
David L. Porter & Joseph H. Antin. 1997. Blood Stem Cell Transplantation. Blood Stem Cell Transplantation 57 85 .
Gustavo Antonio Moviglia. (1996) Development of tumor B-cell lymphocyte hybridoma (TBH) autovaccination. Results of a phase I-II clinical trial. Transfusion Science 17:4, pages 643-649.
Crossref
Robin Foa, Alessandro Cignetti & Anna Guarini. (2012) Acute Leukaemia. Clinical Immunotherapeutics 6:3, pages 238-249.
Crossref
V. Schirrmacher, V. Umansky & M. Rocha. 1996. Attempts to Understand Metastasis Formation III. Attempts to Understand Metastasis Formation III 189 216 .
Volker Schirrmacher, Egbert Hagm�ller, Thomas Lehnert, Sigmund Pomer, Thorsten Ahlert, Detlef Ockert & Peter Schlag. (1995) Biotherapy of cancer. Journal of Cancer Research and Clinical Oncology 121:8, pages 443-451.
Crossref
E. Naparstek, R. Or, A. Nagler, G. Cividalli, D. Engelhard, M. Aker, Z. Gimon, N. Manny, T. Sacks, Z. Tochner, L. Weiss, S. Samuel, C. Brautbar, G. Hale, H. Waldmann, S. M. Steinberg & S. SLAVIN. (2008) T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapse. British Journal of Haematology 89:3, pages 506-515.
Crossref
Arnon Nagler, Shimon Slavin, Shai Yarkoni, M. Fejgin & Aliza Amiel. (1994) Detection of minimal residual disease after sex-mismatch bone marrow transplantation in chronic myelogenous leukemia by fluorescence in situ hybridization. Cancer Genetics and Cytogenetics 73:2, pages 130-133.
Crossref
GEOFF HALE & HERMAN WALDMANN. (1994) CAMPATH-1 Monoclonal Antibodies in Bone Marrow Transplantation. Journal of Hematotherapy 3:1, pages 15-31.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.